Copyright
©The Author(s) 2019.
World J Gastroenterol. Mar 21, 2019; 25(11): 1387-1397
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1387
Published online Mar 21, 2019. doi: 10.3748/wjg.v25.i11.1387
Table 4 Summary of the clinical data of the patients who developed recurrent tumors after endoscopic papillectomy
| Age | Sex | Preoperative diagnosis | Final diagnosis | Size (mm) | Resection margin | Duration to recurrence (mo) | Additional treatment | Follow up periods after APC (mo) |
| 75 | Male | Adenoma | Adenoma | 25 | HM (+), VM (X) | 1.0 | APC | 75.9 |
| 60 | Female | Adenoma | Adenoma | 17 | HM (+), VM (X) | 5.0 | APC | 133.4 |
| 73 | Male | Borderline | Adenocarcinoma | 22 | HM (+), VM (-) | 1.2 | APC | 56.6 |
| 74 | Female | Adenoma | Adenoma | n/d | HM (-), VM (-) | 6.3 | APC | 71.0 |
- Citation: Sakai A, Tsujimae M, Masuda A, Iemoto T, Ashina S, Yamakawa K, Tanaka T, Tanaka S, Yamada Y, Nakano R, Sato Y, Kurosawa M, Ikegawa T, Fujigaki S, Kobayashi T, Shiomi H, Arisaka Y, Itoh T, Kodama Y. Clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy. World J Gastroenterol 2019; 25(11): 1387-1397
- URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1387.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i11.1387